Hence, the ApneaLink equipped with the CSR classifier is an appropriate screening tool that may help to prioritize patients with CSR for a polysomnography (PSG). (Weinreich G, Armitstead J, Töpfer V, Wang YM, Teschler, H) The study demonstrated that the screening classifier was able to detect CSR with high diagnostic accuracy. Validation of ApneaLink as screening device for Cheyne–Stokes respiration. The ApneaLink and ApneaLink Plus have been validated in several studies worldwide Validation of MicroMESAM 2 as screening device for sleep-disordered breathing (Wang Y, Teschler T, Weinreich G, Hess S, Wessendorf TE, Teschler H) MicroMESAM-generated flow-time curves correspond well with pneumotachograph-generated curves, producing automated AHIs 3 that are highly sensitive in detecting SDB. The device reports apneas, hypopneas, flow limitation, snoring, blood oxygen saturation and the probability of Cheyne–Stokes respiration (CSR) breathing patterns within the recording. The ApneaLink devices provide you with a cost-effective, easy-to-use method of diagnosing or screening patients for obstructive sleep apnea (OSA) in the home. 1 Now, the detection of this chronically debilitating condition has been made easier with the ApneaLink Plus, a Type III portable monitoring device, the latest addition to the ApneaLink family of diagnostic products and accessories. More than 80% remain undiagnosed, and many barriers prevent patients from getting access to therapy. ApneaLink Plus featuring EasySense technology Sleep-disordered breathing (SDB) is recognized as a serious health problem that impacts approximately 43 million US adults.
0 kommentar(er)
